Literature DB >> 29428668

Immune cells involved in the pathogenesis of ankylosing spondylitis.

Alireza Rezaiemanesh1, Mohsen Abdolmaleki2, Kamal Abdolmohammadi2, Hamideh Aghaei2, Fatemeh Dadgar Pakdel2, Yousef Fatahi3, Narjes Soleimanifar4, Mahdi Zavvar2, Mohammad Hossein Nicknam5.   

Abstract

Ankylosing spondylitis (AS) is an inflammatory autoimmune disease. AS is a prototype form of spondyloarthropathies (SpA). The precise etiology of AS has not been fully understood. But Inflammation has a critical role in the pathogenesis of the disease. The immune system by various cells, secreted-mediators and markers manage and regulate the immune responses and inflammation. Every factor which disturbed this regulation and hemostasis can cause chronic inflammation. In this review, we discussed the role of several innate and adaptive immune cells involved in the triggering, initiation, development, and regulation of AS.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Ankylosing spondylitis; Cytokines; Immune cells; Inflammation

Mesh:

Substances:

Year:  2018        PMID: 29428668     DOI: 10.1016/j.biopha.2018.01.108

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  17 in total

1.  Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory properties.

Authors:  Seyed Shahabeddin Mortazavi-Jahromi; Sepideh Nazeri; Fahimeh Jafarnezhad-Ansariha; Mona Oraei; Abbas Mirshafiey
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

Review 2.  Immune-related adverse events (irAEs) in ankylosing spondylitis (AS) patients treated with interleukin (IL)-17 inhibitors: a systematic review and meta-analysis.

Authors:  Hossein Azadeh; Reza Alizadeh-Navaei; Alireza Rezaiemanesh; Misagh Rajabinejad
Journal:  Inflammopharmacology       Date:  2022-02-21       Impact factor: 4.473

3.  Integration of Immunome With Disease-Gene Network Reveals Common Cellular Mechanisms Between IMIDs and Drug Repurposing Strategies.

Authors:  Abhinandan Devaprasad; Timothy R D J Radstake; Aridaman Pandit
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

4.  A quick decrease of bone marrow edema in sacroiliac joint could be served as a novel marker for dose tapering of etanercept in ankylosing spondylitis patients.

Authors:  Ruishan Yang; Hongda Liu; Mengpo Fan
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

5.  Expression and function of Toll‑like receptors in peripheral blood mononuclear cells in patients with ankylosing spondylitis.

Authors:  Jun Zhang; Rongming Xu; Lei Wu; Jihong Jiang
Journal:  Mol Med Rep       Date:  2019-09-02       Impact factor: 2.952

6.  Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study.

Authors:  Désirée van der Heijde; Lianne S Gensler; Atul Deodhar; Xenofon Baraliakos; Denis Poddubnyy; Alan Kivitz; Mary Katherine Farmer; Dominique Baeten; Nadine Goldammer; Jason Coarse; Marga Oortgiesen; Maxime Dougados
Journal:  Ann Rheum Dis       Date:  2020-04-06       Impact factor: 19.103

Review 7.  The gut-joint axis in spondyloarthritis: immunological, microbial, and clinical insights.

Authors:  Zoya Qaiyum; Melissa Lim; Robert D Inman
Journal:  Semin Immunopathol       Date:  2021-02-24       Impact factor: 11.759

8.  Ankylosing spondylitis: etiology, pathogenesis, and treatments.

Authors:  Xu Cao; Xisheng Weng; Wei Zhu; Xuxia He; Kaiyuan Cheng; Linjie Zhang; Di Chen; Xiao Wang; Guixing Qiu
Journal:  Bone Res       Date:  2019-08-05       Impact factor: 13.567

9.  Gene-regulatory network analysis of ankylosing spondylitis with a single-cell chromatin accessible assay.

Authors:  Haiyan Yu; Hongwei Wu; Fengping Zheng; Chengxin Zhu; Lianghong Yin; Weier Dai; Dongzhou Liu; Donge Tang; Xiaoping Hong; Yong Dai
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

10.  Imbalance of Peripheral Lymphocyte Subsets in Patients With Ankylosing Spondylitis: A Meta-Analysis.

Authors:  Dong Liu; Budian Liu; Churong Lin; Jieruo Gu
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.